Literature DB >> 10712906

The conformation of the transcription factor TFIIB modulates the response to transcriptional activators in vivo.

N A Hawkes1, R Evans, S G Roberts.   

Abstract

The general transcription factor TFIIB plays a crucial role in the assembly of the transcriptional preinitiation complex and has also been proposed as a target of transcriptional activator proteins (reviewed in [1]). TFIIB is composed of two domains which are engaged in an intramolecular interaction that is disrupted upon interaction with the activation domain of the Herpesvirus VP16 protein in vitro [2] [3]. The significance of this event for transcriptional activation is not known, however. The amino-terminal intramolecular interaction domain is the most conserved region of TFIIB and plays a role in transcription start-site selection [4] [5] [6]. In addition, we have shown previously that the integrity of this region is required for transcriptional activation in vivo [4]. Here, we have defined a charge cluster at the amino terminus of TFIIB that is required for transcriptional activation in vivo. We found that this domain determines the affinity of the TFIIB intramolecular interaction and the ability of TFIIB to interact with a transcriptional activation domain, but not with components of the holoenzyme. Our results suggest that the intramolecular interaction in TFIIB regulates transcriptional activation in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712906     DOI: 10.1016/s0960-9822(00)00363-8

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  12 in total

1.  Activator-mediated disruption of sequence-specific DNA contacts by the general transcription factor TFIIB.

Authors:  R Evans; J A Fairley; S G Roberts
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Core promoter-dependent TFIIB conformation and a role for TFIIB conformation in transcription start site selection.

Authors:  Jennifer A Fairley; Rachel Evans; Nicola A Hawkes; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

3.  A conformational change in TFIIB is required for activator-mediated assembly of the preinitiation complex.

Authors:  James A Glossop; Tim R Dafforn; Stefan G E Roberts
Journal:  Nucleic Acids Res       Date:  2004-03-22       Impact factor: 16.971

Review 4.  TFIIB and the regulation of transcription by RNA polymerase II.

Authors:  Wensheng Deng; Stefan G E Roberts
Journal:  Chromosoma       Date:  2007-06-26       Impact factor: 4.316

5.  Assembly of transcription factor IIB at a promoter in vivo requires contact with RNA polymerase II.

Authors:  Laura M Elsby; Amanda J M O'Donnell; Laura M Green; Andrew D Sharrocks; Stefan G E Roberts
Journal:  EMBO Rep       Date:  2006-07-28       Impact factor: 8.807

6.  Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talk.

Authors:  Matthew Bratkowski; Ilona Christy Unarta; Lizhe Zhu; Murtada Shubbar; Xuhui Huang; Xin Liu
Journal:  J Biol Chem       Date:  2017-11-20       Impact factor: 5.157

7.  New insights into the role of TFIIB in transcription initiation.

Authors:  Yuming Wang; Stefan Ge Roberts
Journal:  Transcription       Date:  2010-07-06

8.  Phosphorylation of TFIIB links transcription initiation and termination.

Authors:  Yuming Wang; Jennifer A Fairley; Stefan G E Roberts
Journal:  Curr Biol       Date:  2010-03-11       Impact factor: 10.834

9.  The role of TFIIB-RNA polymerase II interaction in start site selection in yeast cells.

Authors:  Dong-Yi Zhang; Daniel J Carson; Jun Ma
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

10.  Probing Zn2+-binding effects on the zinc-ribbon domain of human general transcription factor TFIIB.

Authors:  Mahua Ghosh; Laura M Elsby; Tapas K Mal; Jane M Gooding; Stefan G E Roberts; Mitsuhiko Ikura
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.